American Society of Clinical Oncology

SHERPA: White

People

  1. Ladanyi
    Ladanyi
  2. Scher
    Scher
  3. Offit
    Offit
  4. Antonescu
    Antonescu
  5. Danila
    Danila
  6. Kris
    Kris
  7. Morris
    Morris
  8. Riely
    Riely
  9. Robson
    Robson
  10. Rusch
    Rusch

Groups

  1. GSK Faculty (43)
  2. Department of Medicine (30)
  3. Solid Tumor Oncology Division (28)
  4. Tow Center for Developmental Oncology (TCDO) (16)
  5. Human Oncology and Pathogenesis Program (14)
  6. Sloan Kettering Institute Faculty (13)
  7. Surgery (13)
  8. Molecular Pharmacology and Chemistry Program Faculty (12)
  9. Genitourinary Oncology Service (11)
  10. Epidemiology and Biostatistics (10)
Search Within
  1. "Journal of Clinical Oncology"
  2. "2010"
  3. "GSK Faculty"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (11)
Groups
  1. GSK Faculty (43)
  2. Department of Medicine (30)
  3. Solid Tumor Oncology Division (28)
  4. Tow Center for Developmental Oncology (TCDO) (16)
  5. Human Oncology and Pathogenesis Program (14)
  6. Sloan Kettering Institute Faculty (13)

More Groups

People
  1. Howard Scher (7)
  2. Marc Ladanyi (7)
  3. Steven Larson (6)
  4. Jedd Wolchok (5)
  5. Kenneth Offit (5)
  6. Cristina Antonescu (4)

More People

Years
  1. 2010 (43)
Publications
  1. Journal of Clinical Oncology (43)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes
    Meeting Abstract

    Yang, A.; Kendle, R. F.; Ginsberg, B. A.; Roman, R.; Heine, A. I.; Pogoriler, E.; Yuan, J. D.; Wolchok, J. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Vandetanib (VAN) in locally advance or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA)
    Meeting Abstract

    Wells, S. A.; Robinson, B. G.; Gagel, R. F.; Dralle, H.; Fagin, J. A.; Santoro, M.; Baudin, E.; Vasselli, J. R.; Read, J.; Schlumberger, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib in patients (pts) with ER/PR-negative metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Sparano, J. A.; Caravelli, J.; Patil, S.; Abbruzzi, A.; Hawke, R.; Bromberg, J.; Nonemaker, J.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Mechanism of the antimyeloma activity of PU-H71, a novel purine scaffold HSP90 inhibitor
    Meeting Abstract

    Usmani, S. Z.; Bona, R. D.; Chiosis, G.; Li, Z.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies
    Meeting Abstract

    Sznol, M.; Powderly, J. D.; Smith, D. C.; Brahmer, J. R.; Drake, C. G.; McDermott, D. F.; Lawrence, D. P.; Wolchok, J. D.; Topalian, S. L.; Lowy, I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Chudow, J. J.; Morris, M. J.; Slovin, S. F.; Fine, S.; Fox, J. J.; Larson, S. M.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • In vitro analysis of suicide gene expression and function in human T lymphocytes transduced to express a tumour-targeted chimeric antigen receptor
    Meeting Abstract

    Park, J. H.; Yeh, R.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with newly diagnosed malignant glioma
    Meeting Abstract

    Nghiemphu, P. L.; Omuro, A. M.; Cloughesy, T.; Mellinghoff, I. K.; Norden, A. G.; Nguyen, L. T.; Rajangam, K.; Wen, P. Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save